Modulation of Bone Morphogenetic Protein-9 Expression and Processing by Insulin, Glucose, and Glucocorticoids: Possible Candidate for Hepatic Insulin-Sensitizing Substance

Detalhes bibliográficos
Autor(a) principal: Caperuto, Luciana Chagas [UNIFESP]
Data de Publicação: 2008
Outros Autores: Anhe, Gabriel Forato, Cambiaghi, Tavane David, Akamine, Eliana Hiromi, Buonfiglio, Daniella do Carmo, Cipolla-Neto, Jose, Curi, Rui, Bordin, Silvana
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1210/en.2008-0655
http://repositorio.unifesp.br/handle/11600/31059
Resumo: Bone morphogenetic protein 9 (BMP-9), a member of the TGF-beta superfamily predominantly expressed in nonparenchymal liver cells, has been demonstrated to improve glucose homeostasis in diabetic mice. Along with this therapeutic effect, BMP-9 was proposed as a candidate for the hepatic insulin-sensitizing substance ( HISS). Whether BMP-9 plays a physiological role in glucose homeostasis is still unknown. in the present study, we show that BMP-9 expression and processing is severely reduced in the liver of insulin-resistant rats. BMP-9 expression and processing was directly stimulated by in situ exposition of the liver to the combination of glucose and insulin and oral glucose in overnight fasted rats. Additionally, prolonged fasting ( 72 h) abrogated refeeding-induced BMP-9 expression and processing. Previous exposition to dexamethasone, a known inductor of insulin resistance, reduced BMP-9 processing stimulated by the combination of insulin and glucose. Finally, we show that neutralization of BMP-9 with an anti-BMP-9 antibody induces glucose intolerance and insulin resistance in 12-h fasted rats. Collectively, the present results demonstrate that BMP-9 plays an important role in the control of glucose homeostasis of the normal rat. Additionally, BMP-9 is expressed and processed in an HISS-like fashion, which is impaired in the presence of insulin resistance. BMP-9 regulation according to the feeding status and the presence of diabetogenic factors reinforces the hypothesis that BMP-9 might exert the role of HISS in glucose homeostasis physiology. ( Endocrinology 149: 6326-6335, 2008)
id UFSP_0e2a3a1cb3ee1bb5b4535deccd620fb9
oai_identifier_str oai:repositorio.unifesp.br/:11600/31059
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Modulation of Bone Morphogenetic Protein-9 Expression and Processing by Insulin, Glucose, and Glucocorticoids: Possible Candidate for Hepatic Insulin-Sensitizing SubstanceBone morphogenetic protein 9 (BMP-9), a member of the TGF-beta superfamily predominantly expressed in nonparenchymal liver cells, has been demonstrated to improve glucose homeostasis in diabetic mice. Along with this therapeutic effect, BMP-9 was proposed as a candidate for the hepatic insulin-sensitizing substance ( HISS). Whether BMP-9 plays a physiological role in glucose homeostasis is still unknown. in the present study, we show that BMP-9 expression and processing is severely reduced in the liver of insulin-resistant rats. BMP-9 expression and processing was directly stimulated by in situ exposition of the liver to the combination of glucose and insulin and oral glucose in overnight fasted rats. Additionally, prolonged fasting ( 72 h) abrogated refeeding-induced BMP-9 expression and processing. Previous exposition to dexamethasone, a known inductor of insulin resistance, reduced BMP-9 processing stimulated by the combination of insulin and glucose. Finally, we show that neutralization of BMP-9 with an anti-BMP-9 antibody induces glucose intolerance and insulin resistance in 12-h fasted rats. Collectively, the present results demonstrate that BMP-9 plays an important role in the control of glucose homeostasis of the normal rat. Additionally, BMP-9 is expressed and processed in an HISS-like fashion, which is impaired in the presence of insulin resistance. BMP-9 regulation according to the feeding status and the presence of diabetogenic factors reinforces the hypothesis that BMP-9 might exert the role of HISS in glucose homeostasis physiology. ( Endocrinology 149: 6326-6335, 2008)Univ São Paulo, Dept Fisiol & Biofis, Inst Biomed Sci, BR-05508900 São Paulo, BrazilUniversidade Federal de São Paulo, Dept Biol Sci, BR-04023900 São Paulo, BrazilUniversidade Federal de São Paulo, Dept Biol Sci, BR-04023900 São Paulo, BrazilWeb of ScienceFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Endocrine SocUniversidade de São Paulo (USP)Universidade Federal de São Paulo (UNIFESP)Caperuto, Luciana Chagas [UNIFESP]Anhe, Gabriel ForatoCambiaghi, Tavane DavidAkamine, Eliana HiromiBuonfiglio, Daniella do CarmoCipolla-Neto, JoseCuri, RuiBordin, Silvana2016-01-24T13:51:55Z2016-01-24T13:51:55Z2008-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion6326-6335http://dx.doi.org/10.1210/en.2008-0655Endocrinology. Chevy Chase: Endocrine Soc, v. 149, n. 12, p. 6326-6335, 2008.10.1210/en.2008-06550013-7227http://repositorio.unifesp.br/handle/11600/31059WOS:000261156300047engEndocrinologyinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2016-01-24T11:51:55Zoai:repositorio.unifesp.br/:11600/31059Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652016-01-24T11:51:55Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Modulation of Bone Morphogenetic Protein-9 Expression and Processing by Insulin, Glucose, and Glucocorticoids: Possible Candidate for Hepatic Insulin-Sensitizing Substance
title Modulation of Bone Morphogenetic Protein-9 Expression and Processing by Insulin, Glucose, and Glucocorticoids: Possible Candidate for Hepatic Insulin-Sensitizing Substance
spellingShingle Modulation of Bone Morphogenetic Protein-9 Expression and Processing by Insulin, Glucose, and Glucocorticoids: Possible Candidate for Hepatic Insulin-Sensitizing Substance
Caperuto, Luciana Chagas [UNIFESP]
title_short Modulation of Bone Morphogenetic Protein-9 Expression and Processing by Insulin, Glucose, and Glucocorticoids: Possible Candidate for Hepatic Insulin-Sensitizing Substance
title_full Modulation of Bone Morphogenetic Protein-9 Expression and Processing by Insulin, Glucose, and Glucocorticoids: Possible Candidate for Hepatic Insulin-Sensitizing Substance
title_fullStr Modulation of Bone Morphogenetic Protein-9 Expression and Processing by Insulin, Glucose, and Glucocorticoids: Possible Candidate for Hepatic Insulin-Sensitizing Substance
title_full_unstemmed Modulation of Bone Morphogenetic Protein-9 Expression and Processing by Insulin, Glucose, and Glucocorticoids: Possible Candidate for Hepatic Insulin-Sensitizing Substance
title_sort Modulation of Bone Morphogenetic Protein-9 Expression and Processing by Insulin, Glucose, and Glucocorticoids: Possible Candidate for Hepatic Insulin-Sensitizing Substance
author Caperuto, Luciana Chagas [UNIFESP]
author_facet Caperuto, Luciana Chagas [UNIFESP]
Anhe, Gabriel Forato
Cambiaghi, Tavane David
Akamine, Eliana Hiromi
Buonfiglio, Daniella do Carmo
Cipolla-Neto, Jose
Curi, Rui
Bordin, Silvana
author_role author
author2 Anhe, Gabriel Forato
Cambiaghi, Tavane David
Akamine, Eliana Hiromi
Buonfiglio, Daniella do Carmo
Cipolla-Neto, Jose
Curi, Rui
Bordin, Silvana
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Caperuto, Luciana Chagas [UNIFESP]
Anhe, Gabriel Forato
Cambiaghi, Tavane David
Akamine, Eliana Hiromi
Buonfiglio, Daniella do Carmo
Cipolla-Neto, Jose
Curi, Rui
Bordin, Silvana
description Bone morphogenetic protein 9 (BMP-9), a member of the TGF-beta superfamily predominantly expressed in nonparenchymal liver cells, has been demonstrated to improve glucose homeostasis in diabetic mice. Along with this therapeutic effect, BMP-9 was proposed as a candidate for the hepatic insulin-sensitizing substance ( HISS). Whether BMP-9 plays a physiological role in glucose homeostasis is still unknown. in the present study, we show that BMP-9 expression and processing is severely reduced in the liver of insulin-resistant rats. BMP-9 expression and processing was directly stimulated by in situ exposition of the liver to the combination of glucose and insulin and oral glucose in overnight fasted rats. Additionally, prolonged fasting ( 72 h) abrogated refeeding-induced BMP-9 expression and processing. Previous exposition to dexamethasone, a known inductor of insulin resistance, reduced BMP-9 processing stimulated by the combination of insulin and glucose. Finally, we show that neutralization of BMP-9 with an anti-BMP-9 antibody induces glucose intolerance and insulin resistance in 12-h fasted rats. Collectively, the present results demonstrate that BMP-9 plays an important role in the control of glucose homeostasis of the normal rat. Additionally, BMP-9 is expressed and processed in an HISS-like fashion, which is impaired in the presence of insulin resistance. BMP-9 regulation according to the feeding status and the presence of diabetogenic factors reinforces the hypothesis that BMP-9 might exert the role of HISS in glucose homeostasis physiology. ( Endocrinology 149: 6326-6335, 2008)
publishDate 2008
dc.date.none.fl_str_mv 2008-12-01
2016-01-24T13:51:55Z
2016-01-24T13:51:55Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1210/en.2008-0655
Endocrinology. Chevy Chase: Endocrine Soc, v. 149, n. 12, p. 6326-6335, 2008.
10.1210/en.2008-0655
0013-7227
http://repositorio.unifesp.br/handle/11600/31059
WOS:000261156300047
url http://dx.doi.org/10.1210/en.2008-0655
http://repositorio.unifesp.br/handle/11600/31059
identifier_str_mv Endocrinology. Chevy Chase: Endocrine Soc, v. 149, n. 12, p. 6326-6335, 2008.
10.1210/en.2008-0655
0013-7227
WOS:000261156300047
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Endocrinology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 6326-6335
dc.publisher.none.fl_str_mv Endocrine Soc
publisher.none.fl_str_mv Endocrine Soc
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268362454204416